Feb 28, 2025
Tim Tobin, CEO and Founder of Planatome, has a background in the semiconductor industry where precision polishing techniques were developed. Planatome has used that technology to create molecularly smooth scalpel blades that remove all the jagged edges on traditional surgical scalpels. These new nano polished...
Feb 28, 2025
Tim Tobin, CEO and Founder of Planatome, has a background in the semiconductor industry where precision polishing techniques were developed. Planatome has used that technology to create molecularly smooth scalpel blades that remove all the jagged edges on traditional surgical scalpels. These new nano polished...
Feb 27, 2025
Kiran Nistala, Chief Medical Officer and head of development at Zura Bio, describes how their novel molecules target multiple pathways to provide more effective treatments for patients with autoimmune diseases. This is particularly necessary for those with complex, heterogeneous manifestations not well addressed by...
Feb 27, 2025
Kiran Nistala, Chief Medical Officer and head of development at Zura Bio, describes how their novel molecules target multiple pathways to provide more effective treatments for patients with autoimmune diseases. This is particularly necessary for those with complex, heterogeneous manifestations not well addressed by...
Feb 26, 2025
Dr. Rafael Amado, President, Head of Global Research and Development at Zai Lab, highlights the renewed interest in antibody-drug conjugates (ADCs) with advancements in linker technology and payload delivery, leading to improved therapeutic windows and reduced side effects. The Zai Lab lead ADC ZL-1310 has shown...